Clinical trial

Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants

NCT00761605

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE4

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2014-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

PaliperidoneDRUG · verified · RxNorm: paliperidone

Sponsors & collaborators

Janssen Korea, Ltd., Korealead sponsor

Mapped research locations

SeoulSouth Korea1 IncheonSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00761605 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.